» Articles » PMID: 18174874

The Utility of Serum C-reactive Protein in Differentiating Bacterial from Nonbacterial Pneumonia in Children: a Meta-analysis of 1230 Children

Overview
Specialty Pediatrics
Date 2008 Jan 5
PMID 18174874
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Differentiating bacterial from nonbacterial community-acquired pneumonia in children is difficult. Although several studies have evaluated serum concentrations of C-reactive protein (CRP) as a predictor of bacterial pneumonia in this patient population, the utility of this test remains unclear.

Objective: The purpose of this meta-analysis was to quantitatively define the utility of serum CRP as a predictor of bacterial pneumonia in acutely ill children.

Methods: Multiple databases were searched, bibliographies reviewed, and 2 authorities in the field were queried. Studies were included if: (1) the patient population was between 1 month and 18 years of age; (2) CRP was quantified in all subjects as part of the initial evaluation of a suspected, infectious, pulmonary process; (3) a cutoff serum CRP concentration between 30 and 60 mg/dL was used to distinguish nonbacterial from bacterial pneumonia; (4) some criteria were applied to differentiate bacterial from nonbacterial or viral pneumonia; (5) all patients were acutely ill; and (6) a chest radiograph was obtained as part of the initial evaluation. The quality of each included study was determined across 4 metrics: diagnostic criteria; study design; exclusion of chronically ill or human immunodeficiency virus infected subjects; and exclusion of patients who recently received antibiotics. Data was extracted from each article; the primary outcome measure was the odds ratio of patients with bacterial or mixed etiology pneumonia and serum CRP concentrations exceeding 30-60 mg/L. Heterogeneity among the studies was determined by Cochran's Q statistic; the methods of both Mantel and Haenszel, and DerSimonian and Laird were used to combine the study results.

Results: Eight studies fulfilled inclusion criteria. Combining all of the studies demonstrated a pooled study population of 1230 patients with the incidence of bacterial infection of 41%. Children with bacterial pneumonia were significantly more likely to have serum CRP concentrations exceeding 35-60 mg/L than children with nonbacterial infections (odds ratio = 2.58, 95% confidence interval = 1.20-5.55). Sensitivity analysis demonstrated that this difference was robust. There was significant heterogeneity among the 8 studies (Q = 37.7, P < 0.001, I2 = 81.4) that remained throughout the sensitivity analysis.

Conclusions: In children with pneumonia, serum CRP concentrations exceeding 40-60 mg/L weakly predict a bacterial etiology.

Citing Articles

Etiology and Clinical Prediction of Community-Acquired Lower Respiratory Tract Infection in Children.

Yoo B, Yune I, Kang D, Cho Y, Lim S, Yoo S J Korean Med Sci. 2025; 40(2):e5.

PMID: 39807004 PMC: 11729236. DOI: 10.3346/jkms.2025.40.e5.


Comparison of commercially available, rapid, point-of-care C-reactive protein assays among children with febrile illness in southwestern Uganda.

Cassidy C, Kabugho L, Kibaba G, Lin B, Hollingsworth B, Baguma E PLOS Glob Public Health. 2024; 4(1):e0002727.

PMID: 38241274 PMC: 10798459. DOI: 10.1371/journal.pgph.0002727.


Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children.

Zhang X, Zhang X, Hua W, Xie Z, Liu H, Zhang H World J Pediatr. 2023; 20(1):11-25.

PMID: 38064012 PMC: 10828005. DOI: 10.1007/s12519-023-00777-9.


Novel care pathway to optimise antimicrobial prescribing for uncomplicated community-acquired pneumonia: study protocol for a prospective before-after cohort study in the emergency department of a tertiary care Canadian children's hospital.

Pernica J, Kam A, Eltorki M, Khan S, Goldfarb D, Smaill F BMJ Open. 2022; 12(11):e062360.

PMID: 36396301 PMC: 9677018. DOI: 10.1136/bmjopen-2022-062360.


Tomography and Prognostic Indices in the State of the Art of Evaluation in Hospitalized Patients with COVID-19 Pneumonia.

Criales-Vera S, Saucedo-Orozco H, Iturralde-Torres P, Martinez-Mota G, Davila-Medina E, Guarner-Lans V Pathogens. 2022; 11(11).

PMID: 36365031 PMC: 9697491. DOI: 10.3390/pathogens11111281.